Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...

The state-branded, life-saving drugs for some 3.5 million Californians with diabetes will be much cheaper, the governor ...

Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

The Trump administration has determined the U.S. is in a "non-international armed conflict" with drug cartels it has designated as terrorist organizations, it said in a notification to Congress viewed ...

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: ...

-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...

The Trump administration on Sunday renewed its request to a federal appeals court to fire Lisa Cook, a Federal Reserve governor who has faced political scrutiny in recent weeks. The move comes ahead ...

A federal appeals court panel on Friday overturned a judge’s block on the Trump administration’s dismantling of the Consumer Financial Protection Bureau (CFPB), paving the way for mass layoffs to ...

The Trump Administration says it will end a $7 billion program to help low-income households and communities get access to affordable solar energy. The move is part of President Trump's effort to ...